Perceived acceptability of self-administered topical therapy for cervical precancer treatment among women undergoing cervical cancer screening in Kenya
| dc.contributor.author | Mungo, Chemtai | |
| dc.contributor.author | Ellis, Grace | |
| dc.contributor.author | Rop, Mercy | |
| dc.contributor.author | Zou, Yating | |
| dc.contributor.author | Omoto, Jackton | |
| dc.contributor.author | Rahangdale, Lisa | |
| dc.date.accessioned | 2024-03-13T16:29:33Z | |
| dc.date.available | 2024-03-13T16:29:33Z | |
| dc.date.issued | 2024-03-05 | |
| dc.identifier.uri | https://repository.maseno.ac.ke/handle/123456789/6026 | |
| dc.description.abstract | Innovative strategies are urgently needed to meet the World Health Organizations 2030 target of treating 90% of women with precancerous cervical lesions, especially in countries most affected by cervical cancer. We assessed the acceptability of self-administered intravaginal therapies for treating cervical precancer in women undergoing cervical cancer screening and precancer treatment in Kenya. | en_US |
| dc.publisher | Cold Spring Harbor Laboratory Press | en_US |
| dc.title | Perceived acceptability of self-administered topical therapy for cervical precancer treatment among women undergoing cervical cancer screening in Kenya | en_US |
| dc.type | Article | en_US |